HCA Healthcare [HCA] vs Encompass Health [EHC] Detailed Stock Comparison
HCA Healthcare
NYSE
Loading...
Encompass Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: HCA Healthcare wins in 14 metrics, Encompass Health wins in 6 metrics, with 0 ties. HCA Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | HCA Healthcare | Encompass Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 14.99 | 22.33 | HCA Healthcare |
| Price-to-Book Ratio | -198.01 | 5.07 | HCA Healthcare |
| Debt-to-Equity Ratio | -105.85 | 92.01 | HCA Healthcare |
| PEG Ratio | 14.54 | 22.71 | HCA Healthcare |
| EV/EBITDA | 9.31 | 11.62 | HCA Healthcare |
| Profit Margin (TTM) | 8.21% | 8.97% | Encompass Health |
| Operating Margin (TTM) | 15.95% | 18.35% | Encompass Health |
| EBITDA Margin (TTM) | 15.95% | 18.35% | Encompass Health |
| Return on Equity | 13,631.68% | 24.58% | HCA Healthcare |
| Return on Assets (TTM) | 11.84% | 8.97% | HCA Healthcare |
| Free Cash Flow (TTM) | $5.64B | $360.30M | HCA Healthcare |
| Dividend Yield | 0.54% | 0.55% | Encompass Health |
| 1-Year Return | 0.17% | 17.06% | Encompass Health |
| Price-to-Sales Ratio (TTM) | 1.18 | 1.98 | HCA Healthcare |
| Enterprise Value | $134.94B | $14.32B | HCA Healthcare |
| EV/Revenue Ratio | 1.86 | 2.60 | HCA Healthcare |
| Gross Profit Margin (TTM) | 84.91% | 43.35% | HCA Healthcare |
| Revenue per Share (TTM) | $293 | $55 | HCA Healthcare |
| Earnings per Share (Diluted) | $23.81 | $4.86 | HCA Healthcare |
| Beta (Stock Volatility) | 1.48 | 0.76 | Encompass Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
HCA Healthcare vs Encompass Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| HCA Healthcare | 0.84% | 6.77% | -8.36% | 4.06% | 6.78% | 19.89% |
| Encompass Health | -1.43% | 0.80% | -9.87% | -6.39% | 7.90% | 18.16% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| HCA Healthcare | 0.17% | 67.74% | 174.02% | 290.30% | 1,047.08% | 1,047.08% |
| Encompass Health | 17.06% | 105.12% | 101.77% | 204.01% | 655.78% | 374.55% |
Performance & Financial Health Analysis: HCA Healthcare vs Encompass Health
| Metric | HCA | EHC |
|---|---|---|
| Market Information | ||
| Market Cap | $85.88B | $10.94B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,992,000 | 917,540 |
| 90 Day Avg. Volume | 1,613,657 | 973,067 |
| Last Close | $356.97 | $108.53 |
| 52 Week Range | $289.98 - $417.14 | $82.74 - $123.13 |
| % from 52W High | -14.42% | -11.86% |
| All-Time High | $417.14 (Oct 14, 2024) | $123.13 (Jun 04, 2025) |
| % from All-Time High | -14.42% | -11.86% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.11% |
| Quarterly Earnings Growth | 0.13% | 0.35% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.09% |
| Operating Margin (TTM) | 0.16% | 0.18% |
| Return on Equity (TTM) | 136.32% | 0.25% |
| Debt to Equity (MRQ) | -105.85 | 92.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-18.16 | $21.40 |
| Cash per Share (MRQ) | $3.88 | $0.95 |
| Operating Cash Flow (TTM) | $11.93B | $1.05B |
| Levered Free Cash Flow (TTM) | $5.49B | $235.85M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.54% | 0.55% |
| Last 12-Month Dividend | $2.04 | $0.66 |
Valuation & Enterprise Metrics Analysis: HCA Healthcare vs Encompass Health
| Metric | HCA | EHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 14.99 | 22.33 |
| Forward P/E | 14.54 | 22.71 |
| PEG Ratio | 14.54 | 22.71 |
| Price to Sales (TTM) | 1.18 | 1.98 |
| Price to Book (MRQ) | -198.01 | 5.07 |
| Market Capitalization | ||
| Market Capitalization | $85.88B | $10.94B |
| Enterprise Value | $134.94B | $14.32B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.86 | 2.60 |
| Enterprise to EBITDA | 9.31 | 11.62 |
| Risk & Other Metrics | ||
| Beta | 1.48 | 0.76 |
| Book Value per Share (MRQ) | $-18.16 | $21.40 |
Financial Statements Comparison: HCA Healthcare vs Encompass Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HCA | EHC |
|---|---|---|
| Revenue/Sales | $18.32B | $1.46B |
| Cost of Goods Sold | $2.76B | $824.50M |
| Gross Profit | $15.56B | $630.90M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $2.86B | $267.00M |
| EBITDA | $3.73B | $349.60M |
| Pre-Tax Income | $2.33B | $238.60M |
| Income Tax | $502.00M | $41.60M |
| Net Income (Profit) | $1.83B | $196.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HCA | EHC |
|---|---|---|
| Cash & Equivalents | $1.06B | $95.80M |
| Total Current Assets | $16.26B | $910.90M |
| Total Current Liabilities | $13.63B | $856.00M |
| Long-Term Debt | $42.92B | $2.54B |
| Total Shareholders Equity | $-438.00M | $2.94B |
| Retained Earnings | $-3.16B | $930.80M |
| Property, Plant & Equipment | $65.81B | $3.94B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HCA | EHC |
|---|---|---|
| Operating Cash Flow | $2.65B | $289.30M |
| Capital Expenditures | $-991.00M | $-163.10M |
| Free Cash Flow | $660.00M | $125.50M |
| Debt Repayment | $-3.90B | $-80.00M |
| Common Stock Repurchase | $-2.51B | $-32.10M |
Short Interest & Institutional Ownership Analysis
| Metric | HCA | EHC |
|---|---|---|
| Shares Short | 3.89M | 988,914 |
| Short Ratio | 2.67 | 1.08 |
| Short % of Float | 0.02% | 0.01% |
| Average Daily Volume (10 Day) | 1,992,000 | 917,540 |
| Average Daily Volume (90 Day) | 1,613,657 | 973,067 |
| Shares Outstanding | 249.98M | 100.78M |
| Float Shares | 169.07M | 99.41M |
| % Held by Insiders | 0.30% | 0.01% |
| % Held by Institutions | 0.66% | 0.97% |
Dividend Analysis & Yield Comparison: HCA Healthcare vs Encompass Health
| Metric | HCA | EHC |
|---|---|---|
| Last 12-Month Dividend | $2.04 | $0.66 |
| Last 12-Month Dividend Yield | 0.54% | 0.55% |
| 3-Year Avg Annual Dividend | $2.29 | $3.68 |
| 3-Year Avg Dividend Yield | 0.22% | 1.66% |
| 3-Year Total Dividends | $6.88 | $11.04 |
| Ex-Dividend Date | Mar 17, 2025 | Apr 01, 2025 |